%20(1).png)
About Neurometry
Neurometry is a cognitive health platform built at the intersection of neuroscience, digital technology, and patient experience. We aim to make cognitive recovery measurable, accessible, and empowering.
Mission
Neurometry is a cognitive health platform built at the intersection of neuroscience, digital technology, and patient experience. We aim to make cognitive recovery measurable, accessible, and empowering.
Our Story
Neurometry began as a neuroscience research project at the University of Bern and evolved through the King’s College MedTech Accelerator and London Business School Incubator. Today, our technology supports NHS Trusts and academic partners working across stroke, neuropsychiatry, and neurodegeneration.
Leadership Team
Omair Ahmed, CEO
A biotech and finance entrepreneur with a strong foundation in statistics, he has contributed to multiple MedTech and Biotech ventures across cardiology, immunology, pain management, and neuro-inflammatory applications. His experience includes leadership roles at AbCelex Technology and the spinoff of Orpheus Medica, as well as advisory work for Kondor Pharma.
Previously, he spent 12 years in derivatives trading and portfolio management at RBC Royal Bank and BMO Capital Markets, later founding Taunton Capital LLP, a systematic trading fund. His work was recognized at the World Economic Forum’s COVID-19 Response Challenge in 2020.
He holds an MSc in Quantitative Finance from London Business School and an Honours BA in Econometrics and Theology from the University of Toronto, and is an active member of the Milken Institute and FasterCures. His interdisciplinary background informs his leadership at Neurometry.
Dr Prabitha Urwyler, Biomedical Scientist
She is a distinguished clinical researcher with a diverse 13-year background in software engineering within the Tech and Media sectors. Her journey began with a PhD focused on the fabrication, characterization, and application of disposable microcantilevers for biomedical purposes. She continued her postdoctoral research at the Biomaterials Science Centre, University of Basel,followed by the University Hospital of Psychiatry in Bern. She served as a researcher and deputy group head at the Gerontechnology and Rehabilitation Group, ARTORG Center at the University of Bern, and as a scientific officer and program manager at Innosuisse, the Swiss Innovation Agency. Her extensive research career spans nanotechnology, biosensors, biomaterials, implant surface characterization, micro/nanofabrication, neuroscience, psychiatry, neurodegenerative diseases, gerontechnology, ambient assisted living, telehealth, and rehabilitation. She holds a Bachelor of Technology in Computer Science & Engineering from Mangalore University, an MSc in Biomedical Engineering from the University of Bern, a PhD in Biomedical Engineering from the University of Basel and the Paul Scherrer Institute, and a Venia Docendi (PD) from the University of Bern. Dr. Urwyler’s interdisciplinary expertise and passion for improving quality of life through innovative biomedical solutions make her an invaluable leader at Neurometry. make this brief too
Dr Christoph Mueller
Christoph Mueller is a Reader in Ageing and Mental Health Data Science at King’s College London and a Consultant Old Age Psychiatrist within the NHS. He is in the same clinical team with Dr. Latha Velayudhan His research focuses on dementia and mental health in later life, using large-scale electronic health records and advanced clinical informatics. He leads work on disease progression, treatment outcomes, and digital interventions, and actively bridges academic research with clinical practice and public engagement.
Dr Rohit Shankar
Dr Rohit Shankar is Professor of Neuropsychiatry at the University of Plymouth and an NHS Consultant Neuropsychiatrist, with honorary appointments at Exeter Medical School. An MBE and Royal College of Psychiatrists Fellow, he leads internationally recognised research in epilepsy, SUDEP, and intellectual disability, and has authored 300+ peer-reviewed publications. (edited)
A neuroscientist and neurotechnology innovator focused on building products, datasets, and analytical systems that transform complex brain data into practical tools for healthcare, research, and industry. Over the past decade, he has founded a neuromarketing agency and developed patented methods, multimodal datasets, and clinically relevant neurotechnologies.
He recently released one of the most comprehensive naturalistic neuroimaging databases to date, combining fMRI, eye-tracking, and cognitive tasks, now used by multiple research groups. At Neurometry, he develops digital biomarkers and algorithms for cognitive health, contributes patented EEG analysis techniques, and designs hardware solutions to improve MRI data quality.
His work is published in leading peer-reviewed journals and featured in public media, operating at the intersection of science, engineering, and product innovation.
Dr Latha Velayudhan
Dr Latha Velayudhan is a clinical reader in ageing and dementia studies at the Institute of Psychiatry, Psychology and Neurosciences (IoPPN), Kings College London. Latha is also a consultant psychiatrist at the South London & Maudsley NHS Foundation Trust (SLaM) and leads the Lewisham Memory Service. Latha is a clinician-academic with research interests in neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). Her main research work includes investigating neuropsychiatric symptoms, smell identification dysfunction, biomarkers such as blood protein markers and neuroimaging, and conducting clinical trials, currently using cannabinoid medications for neuropsychiatric symptoms in AD and PD.
Clinical Partners
David McDowell
An entrepreneurial CEO with over 25 years of experience founding and operating B2B and B2C online gaming and sports betting ventures. He has led teams across every functional area of gaming businesses and has supported the launch of more than 50 brands across four continents. His experience includes leading angel, VC, and private equity funding rounds, as well as achieving exits via trade sales and IPOs.
He began his career as a manufacturing engineer in Michigan before earning an MBA from London Business School and transitioning into entrepreneurship. After launching his first venture in Toronto, he returned to London for a management consulting role and subsequently built a career in online gaming and sports betting.
He currently runs a private consulting practice and serves as an Entrepreneur Mentor in Residence at London Business School, supporting early-stage founders from inception through exit.
Investors
Joe Baddoura, Sr Director
Senior healthcare executive formerly at Mass General Psychiatry Hospital and strategist with expertise in operations, finance, and growth. Proven leader in driving service expansion, enhancing patient access, and optimizing performance. Skilled in revenue optimization, M&A, and building high-performing teams in complex healthcare environments.
Michelle is Senior Partner and been with Candesic since 2004. Michelle spent over a decade as a front-line hospital doctor before joining Candesic.
Michelle is an experienced Board member and delivered global growth by evidencing improved clinical outcomes alongside financial returns. She edited ‘The Future of the NHS’ and authored ‘Big Brain Revolution: Artificial Intelligence – Spy or Saviour?’. She qualified as a doctor at Cambridge University, has a legal masters and is a Cambridge Angel. She is on the digital council at the Royal Society of Medicine and mentor’s start-ups.